Skip to content
Clinical Trials – home

Sanos A/S

Verified siteinfo

Denmark Borgergade 39, 9362 Gandrup, Denmark

  • 12 trials recruiting
  • Osteoarthritis · Obesity · Arteriosclerosis
  • Adults and children

About Specializations

Sanos A/S in Gandrup, Denmark specialises in clinical trials of conditions such as Osteoarthritis, Obesity, Arteriosclerosis, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Sanos A/S in Gandrup, a large share of the research focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease, hypertension, and conditions linked to elevated lipoprotein(a). These studies are designed to test new ways to reduce heart attack, stroke, and other major cardiovascular complications, while also improving prevention in people at high risk.

  • Testing treatments aimed at lowering cardiovascular risk in people with established disease or high-risk profiles
  • Studying therapies for elevated Lp(a) and related lipid disorders
  • Evaluating approaches to prevent major events such as myocardial infarction, stroke, and urgent revascularization

This area includes research on both prevention and long-term risk reduction, reflecting a strong emphasis on improving outcomes for people with serious heart and vascular disease.

Immune System Diseases

The site also conducts extensive trials in immune system diseases, with work centered on atopic dermatitis, psoriasis, rheumatoid arthritis, and polymyalgia rheumatica. These studies aim to better control inflammation, ease symptoms, and assess the safety and effectiveness of newer treatment options for chronic immune-mediated conditions.

  • Exploring therapies for atopic dermatitis, including long-term symptom control
  • Evaluating treatments for psoriasis and related inflammatory skin disease
  • Studying medicines for rheumatoid arthritis and polymyalgia rheumatica to improve disease control

Much of this research is focused on reducing disease activity and supporting durable treatment benefit in people living with persistent inflammatory disorders.

Musculoskeletal Diseases

A major research theme at Sanos A/S is musculoskeletal disease, particularly knee osteoarthritis, osteoarthritis, rotator cuff tendinopathy, and knee synovitis. These trials are aimed at finding better ways to relieve pain, improve function, and support joint health in people affected by chronic movement-related conditions.

  • Investigating treatments for knee osteoarthritis and associated pain
  • Assessing options to improve joint function and physical symptoms
  • Exploring approaches that may help protect or restore cartilage and joint structure

This field combines symptom relief with efforts to address the underlying burden of degenerative joint disease.

Nervous System Diseases

The research portfolio includes nervous system diseases such as migraine and Alzheimer’s disease. These studies are intended to improve prevention of migraine attacks, reduce headache burden, and assess new options for supporting people with neurodegenerative disease.

  • Studying preventive treatments for chronic migraine and episodic migraine
  • Evaluating therapies for early Alzheimer’s disease
  • Focusing on better symptom control and improved quality of life in neurological conditions

Overall, this area reflects a mix of symptom prevention and disease-focused research in conditions that can have a major impact on daily life.

Nutritional and Metabolic Diseases

Research in nutritional and metabolic diseases at this site is centered on obesity, overweight, type 2 diabetes, and related weight-management conditions. The trials are designed to evaluate new therapies that may help people lose weight, improve metabolic health, and lower the risk of complications linked to excess body weight.

  • Testing treatments for weight reduction in people with obesity or overweight
  • Studying therapies for type 2 diabetes and related metabolic risk
  • Assessing whether weight-focused treatments can also improve cardiovascular and joint outcomes

This area links metabolic health with broader disease prevention, including effects on the heart and joints.

Skin and Connective Tissue Diseases

The site runs trials in skin and connective tissue diseases such as acne vulgaris, vitiligo, pruritus, and atopic dermatitis. These studies are focused on improving skin symptoms, reducing visible disease burden, and testing new therapies for both inflammatory and chronic dermatologic conditions.

  • Evaluating treatments for acne vulgaris and other common skin conditions
  • Studying therapies for vitiligo and pruritus
  • Assessing options for long-term control of inflammatory skin disease

This research aims to improve both symptom relief and everyday well-being for people with chronic dermatologic disorders.

Virus Diseases

In the area of virus diseases, the research includes work related to the HPV vaccine and prevention of infections that can lead to cervical cancer and genital warts. The purpose of these studies is to better understand long-term protection and support public health prevention strategies.

  • Examining the effectiveness of HPV vaccination over time
  • Supporting prevention of HPV-related cancers and precancerous lesions
  • Contributing to broader infectious disease prevention efforts

This work adds a preventive dimension to the site’s portfolio, with emphasis on reducing future disease burden through vaccination research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Borgergade 399362 GandrupDenmark
Recruiting now
12 trials
Conditions studied
15
Partner status
Verified site

More sites in GandrupDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

40 clinical trials

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Vitiligo

Recruiting

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity+1

Recruiting

Phase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Study of AZD6234 (lenbelintide) Added to Incretin Therapy in Adults with Obesity or Overweight and a Weight‑Related Comorbidity, With or Without Type 2 Diabetes

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD6234
  • Sponsor:AstraZeneca AB

Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC

Osteoarthritis

Recruiting

Efficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Latigo Biotherapeutics Inc.

Osteoarthritis

Recruiting

Efficacy of intra‑articular allogeneic peripheral blood mononuclear cells induced to an early apoptotic state versus placebo in adults with primary knee osteoarthritis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Peripheral Blood Mononuclear Cells Induced To An Early Apoptotic State
  • Sponsor:Enlivex Therapeutics Ltd.

Obesity+2

Recruiting

Study of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

A study on the long-term effectiveness and safety of nine-valent human papillomavirus vaccine in women aged 16 to 26 years for prevention of cervical cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Merck Sharp & Dohme LLC
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.